摘要
目的 探讨癌痛规范化治疗在肺癌疼痛患者中的应用方法及临床效果。方法 选取2015年4月~2016年6月嘉兴市第一医院收治的120例肺癌疼痛患者作为研究对象,将其随机分为研究组和对照组,各60例,对照组患者施以常规治疗和护理,研究组患者在此基础上施以癌痛规范化治疗和护理,比较2组患者治疗后疼痛状况变化以及不良反应发生情况,并统计患者满意度。结果 治疗前,2组患者VAS评分差异无统计学意义;治疗后2组VAS评分均降低,研究组VAS评分低于对照组,差异具有统计学意义（P〈0.05）;研究组不良反应发生率显著低于对照组,差异具有统计学意义（P〈0.05）;研究组患者治疗后满意度高于对照组,差异具有统计学意义（P〈0.05）。结论 癌痛规范化治疗对于肺癌疼痛患者的临床治疗效果显著,能够有效减轻患者疼痛,提升患者生存质量和满意度。
Objective To explore the application of cancer pain standardized treatment in patients with lung cancer pain and clinical results. Methods 120 cases of lung cancer pain patients as the research object in Our hospital from April 2015 to June 2016, The patients were randomly divided into study group and control group, 60 cases in each group, the patients in the control group were treated with routine therapy and nursing, and he patients in the study group were treated with normalized treatment and care of cancer pain, and then compared the two groups after treatment Pain tatus changes and adverse events and patient satisfaction statistics. Results There was no significant difference in pain status and VAS score between he two groups before treatment, but the pain status was relieved after treatment. The pain status of patients in the study group after standardized reatment of cancer pain changed significantly, the VAS score was lower than the control, the difference between the two groups was statistically ignificant （ P 〈 0. 05 ） . After treatment, the adverse events of the study group including non-on-time medication, syncope pressure sores and the ncidence of self-mutilation or suicide were statistically significant And the difference was statistically significant （ P 〈 0. 05 ） . The satisfaction of the atients in the two groups showed that the satisfaction of the patients in the study group was significantly higher than that of the control group , The difference between groups was statistically significant^ P 〈0. 05）. Conclusion The standardized treatment of cancer pain is effective in the treatment of atients with lung cancer pain. It can effectively relieve the pain and improve the quality of life and satisfaction of patients with lung cancer pain. It has road clinical application and popularization value.
出处
《中国生化药物杂志》
CAS
2017年第4期413-415,共3页
Chinese Journal of Biochemical Pharmaceutics
基金
浙江省医药卫生科技计划项目(2015KYA217)
浙江省医学会临床科研基金项目(2013ZYC-A89)
关键词
肺癌
疼痛
癌痛规范化治疗
lung cancer
pain
cancer pain standardized treatment
